BOSTON, June 30, 2015 /PRNewswire/ -- Juniper Pharmaceuticals, Inc. (Nasdaq: JNP), a specialty pharmaceutical company focused on developing therapeutics that address unmet medical needs in women's health, today announced that CFO George Elston will present at the Cantor Fitzgerald Inaugural Healthcare Conference as follows:
The webcast presentation will be archived for 90 days via the aforementioned URLs.
About Juniper Pharmaceuticals
Juniper Pharmaceuticals, Inc. (Nasdaq: JNP) (formerly Columbia Laboratories) is a specialty pharmaceutical company focused on developing therapeutics that address unmet medical needs in women's health. Juniper has a successful heritage in developing pharmaceutical products, including CRINONE® 8% (progesterone gel), which is marketed by Allergan, Inc. in the U.S. and by Merck Serono S.A. in over 60 countries worldwide. The Company is leveraging in-house pharmaceutical development, clinical trial manufacturing, and analytical capabilities to advance an internal development pipeline, while also providing valuable consultative services to its pharmaceutical industry customers. Please visit www.juniperpharma.com for more information.
Juniper Pharmaceuticals™ and Juniper Pharma Services™ are trademarks of Juniper Pharmaceuticals, Inc., in the U.S. and EU.
CRINONE® is a registered trademark of Allergan, Inc. in the U.S.
Katja Buhrer, MBS Value Partners
Follow us on LinkedIn: https://www.linkedin.com/company/juniper-pharmaceuticals
Logo - http://photos.prnewswire.com/prnh/20150527/218998LOGO
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/juniper-pharmaceuticals-to-present-at-cantor-fitzgerald-inaugural-healthcare-conference-on-july-8-2015-300107062.html
SOURCE Juniper Pharmaceuticals, Inc.